106 related articles for article (PubMed ID: 37022773)
1. Number of Hepatic Resections and Association with Complication after Metastatic Neuroendocrine Tumor Debulking: An American College of Surgeons NSQIP Database Study.
Schwarz JL; Kuchta KM; Rojas A; Mehdi S; Hoon Choi S; Keutgen XM; Talamonti MS; Hogg ME
J Am Coll Surg; 2023 Jul; 237(1):157-168. PubMed ID: 37022773
[TBL] [Abstract][Full Text] [Related]
2. Survey of surgical resections for neuroendocrine liver metastases: A project study of the Japan Neuroendocrine Tumor Society (JNETS).
Aoki T; Kubota K; Kiritani S; Arita J; Morizane C; Masui T; Kudo A; Komoto I; Hatano E; Ito T; Osamura RY; Unno M; Uemoto S; Kokudo N;
J Hepatobiliary Pancreat Sci; 2021 Jun; 28(6):489-497. PubMed ID: 33792204
[TBL] [Abstract][Full Text] [Related]
3. Thirty-Day Morbidity after Simultaneous Resection of Colorectal Cancer and Colorectal Liver Metastasis: American College of Surgeons NSQIP Analysis.
Snyder RA; Hao S; Irish W; Zervos EE; Tuttle-Newhall JE; Parikh AA
J Am Coll Surg; 2020 Apr; 230(4):617-627.e9. PubMed ID: 32007534
[TBL] [Abstract][Full Text] [Related]
4. Improved hemostasis with major hepatic resection in the current surgical era.
Mangieri CW; Strode MA; Bandera BC
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):439-445. PubMed ID: 31307940
[TBL] [Abstract][Full Text] [Related]
5. Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery.
Manning-Geist B; Cathcart AM; Sullivan MW; Pelletier A; Cham S; Muto MG; Del Carmen M; Growdon WB; Sisodia RC; Berkowitz R; Worley M
Int J Gynecol Cancer; 2021 Oct; 31(10):1356-1362. PubMed ID: 34518239
[TBL] [Abstract][Full Text] [Related]
6. Risk of Infectious Complications After Simultaneous Gastrointestinal and Liver Resections for Neuroendocrine Tumor Metastases.
Acosta LF; Chacon E; Eman P; Dugan A; Davenport D; Gedaly R
J Surg Res; 2019 Mar; 235():244-249. PubMed ID: 30691802
[TBL] [Abstract][Full Text] [Related]
7. Examining Perioperative Risk Associated with Simultaneous Resection of Primary Neuroendocrine Tumors and Synchronous Hepatic Metastases.
Heidenreich BM; Kemp Bohan PM; Flor RJ; Bader JO; Vreeland TJ; O'Connor VV; Nelson DW
World J Surg; 2021 Feb; 45(2):531-542. PubMed ID: 33151372
[TBL] [Abstract][Full Text] [Related]
8. Getting started as a hepatobiliary surgeon: lessons learned from the first 100 hepatectomies as a consultant.
Koea J
N Z Med J; 2005 Feb; 118(1210):U1322. PubMed ID: 15776098
[TBL] [Abstract][Full Text] [Related]
9. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive hepatectomy is associated with decreased morbidity and resource utilization in the elderly.
Tee MC; Chen L; Peightal D; Franko J; Kim PT; Brahmbhatt RD; Raman S; Scudamore CH; Chung SW; Segedi M
Surg Endosc; 2020 Nov; 34(11):5030-5040. PubMed ID: 31820156
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.
Foster JM; Sleightholm R; Patel A; Shostrom V; Hall B; Neilsen B; Bartlett D; Smith L
JAMA Netw Open; 2019 Jan; 2(1):e186847. PubMed ID: 30646202
[TBL] [Abstract][Full Text] [Related]
12. Functional status determines postoperative outcomes in elderly patients undergoing hepatic resections.
de la Fuente SG; Bennett KM; Scarborough JE
J Surg Oncol; 2013 Jun; 107(8):865-70. PubMed ID: 23585324
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous colorectal and hepatic procedures for colorectal cancer result in increased morbidity but equivalent mortality compared with colorectal or hepatic procedures alone: outcomes from the National Surgical Quality Improvement Program.
Hamed OH; Bhayani NH; Ortenzi G; Kaifi JT; Kimchi ET; Staveley-O'Carroll KF; Gusani NJ
HPB (Oxford); 2013 Sep; 15(9):695-702. PubMed ID: 23458152
[TBL] [Abstract][Full Text] [Related]
14. The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.
Zaydfudim VM; Kerwin MJ; Turrentine FE; Bauer TW; Adams RB; Stukenborg GJ
Surgery; 2016 May; 159(5):1308-15. PubMed ID: 26747226
[TBL] [Abstract][Full Text] [Related]
15. Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes.
Kinney MAO; Nagorney DM; Clark DF; O'Brien TD; Turner JD; Marienau ME; Schroeder DR; Martin DP
J Clin Anesth; 2018 Dec; 51():93-96. PubMed ID: 30098573
[TBL] [Abstract][Full Text] [Related]
16. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis.
Wiseman JT; Guzman-Pruneda F; Xourafas D; Chun YS; Ejaz A; Tsung A; Pawlik TM; Cloyd JM
J Am Coll Surg; 2019 Jul; 229(1):69-77.e2. PubMed ID: 30905856
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis.
Ejaz A; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM
HPB (Oxford); 2018 Mar; 20(3):277-284. PubMed ID: 28964630
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine hepatic metastatic disease: the surgeon's perspective.
Concors SJ; Maxwell JE
Abdom Radiol (NY); 2022 Dec; 47(12):4073-4080. PubMed ID: 35476146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
